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Abstract
Objective
To assess the frequency of combination of antidepressants with other drugs and risk
of drug interactions in the setting public hospital units in Brazil.
Methods
Prescriptions of all patients admitted to a public hospital from November 1996 to
February 1997 were surveyed from the hospital’s data processing center in São Paulo,
Brazil. A manual search of case notes of all patients admitted to the psychiatric unit
from January 1993 to December 1995 and all patients registered in the affective
disorders outpatient clinic in December 1996 was carried out. Patients taking any
antidepressant were identified and concomitant use of drugs was checked. By means
of a software program (Micromedex) drug interactions were identified.
Results
Out of 6,844 patients admitted to the hospital, 63 (0.9%) used antidepressants and 16
(25.3%) were at risk of drug interaction. Out of 311 patients in the psychiatric unit, 63
(20.2%) used antidepressants and 13 of them (20.6%) were at risk. Out of 87 patients
in the affective disorders outpatient clinic, 43 (49.4%) took antidepressants and 7
(16.2%) were at risk. In general, the use of antidepressants was recorded in 169
patients and 36 (21.3%) were at risk of drug interactions. Twenty different forms of
combinations at risk of drug interactions were identified: four were classified as mild,
15 moderate and one severe interaction.
Conclusion
In the hospital general units the number of drug interactions per patient was higher
than in the psychiatric unit; and prescription for depression was lower than expected.
Resumo
Objetivo
Verificar a freqüência de combinações de antidepressivos com outros medicamentos
e o risco de interações medicamentosas em um hospital público no Brasil.
Métodos
Prescrições de todos os pacientes internados em um hospital público, em São Paulo,
SP, de novembro de 1996 a fevereiro de 1997 foram analisadas pelo centro de
processamento de dados do hospital. Foi realizada busca manual de todos os
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prontuários de pacientes internados na enfermaria de psiquiatria do hospital de
janeiro de 1993 a dezembro de 1995, assim como de todos os pacientes registrados
no ambulatório de doenças afetivas em dezembro de 1996. Foram identificados os
pacientes que usaram algum antidepressivo e as drogas utilizadas concomitantemente.
Foram identificadas pelo programa Micromedex as interações medicamentosas.
Resultados
Dentre os 6.844 pacientes internados nas enfermarias gerais (não psiquiátricas) do
hospital, 63 usaram antidepressivos (0,9%) e 16 (25,3%) usavam medicações com
risco de interação. Dentre os 311 pacientes da enfermaria de psiquiatria, 63 (20,2%)
usavam antidepressivos e 13 (20,6%) apresentavam risco de interação. Dos 87 pacientes
do ambulatório de doenças afetivas, 43 (49,4%) usavam antidepressivos e 7 (16,2%)
apresentavam risco. Em geral, o uso de antidepressivos foi encontrado em 169 pacientes
e 36 (21,3%) estavam em risco de interação medicamentosa. Vinte diferentes tipos de
interações foram identificados, sendo 4 leves, 15 moderados e um grave.
Conclusões
Nas enfermarias gerais o número de interações medicamentosas foi superior em
relação à enfermaria de psiquiatria; e o número de prescrições de antidepressivos foi
menor do que o esperado.
INTRODUCTION
The association of depression with several clinical
conditions has been thoroughly studied.2,3,4,6-10,12,15 Ac-
cording to a study performed in Brazil, 20% of the
patients admitted to a general hospital have depres-
sive symptoms and could benefit from antidepres-
sant treatment.3
However, the use of antidepressants by patients
with other conditions or in use of other medica-
tions require special caution, mainly concerning
drug interaction.1,5,11,13
Drug interaction is defined as modification of the
effect of one drug by previous or concomitant ad-
ministration of another drug. Drug interactions may
be due to pharmacodynamics or pharmacokinetic
causes. Pharmacokinetics comprehends the processes
of drug absorption, distribution, metabolization and
excretion. Pharmacodynamics is related to drug bio-
chemical and physiological processes. The clinically
significant drug interactions with antidepressants are
described in the literature.1
The objective of this study is to assess the frequency
of combination of antidepressants with other drugs
that may result in drug interactions in the setting of
public hospital units (general and psychiatric and
affective disorders outpatient clinic).
METHODS
The present study was carried out in three areas of
the hospital studied: general and psychiatric units,
and affective disorders outpatient clinic. Prescrip-
tions for 6,844 patients admitted to all hospital units
from November 1996 to February 1997 were surveyed
at the hospital’s Data Processing Center. A manual
survey of case notes of all patients admitted to the
psychiatric unit from January 1993 to December 1995
was performed, as well as a manual survey of all case
notes of patients registered in the affective disorders
outpatient clinic in December 1996. Any patient who
took any antidepressant was identified, and then the
drugs concurrently used were checked. By means of
a software program (Micromedex) all possible com-
binations were surveyed.
All antidepressants available were included.
Lithium, valproic acid and carbamazepine were not
included for being considered mood stabilizers and
not exactly antidepressants.
Micromedex is a software program that has an
interactive system to check drug interactions. Ap-
proximately 8,000 medications may be tested as to
possible drug interaction. It also tests drug-food,
drug-diseases, drug-alcohol, and drug-laboratory
tests interactions, classifies interactions as minor,
moderate and major,* and presents interactions
mechanisms and references.
RESULTS
Of the total of patients studied (6,844) in the men-
tioned period, 63 (0.9%) used antidepressants. The
antidepressants used were amitriptyline (n=51**),
*Minor: The interaction would have limited clinical effects. Manifestations may include an increase in the frequency or severity of side effects but generally would not require a
major change in drug therapy. Moderate: The interaction may result in an exacerbation of the patient’s condition and/or require changes in drug therapy. Major: The interaction may
be life-threatening and/or require medical intervention to minimize or prevent serious adverse effects.
**n= number of times the medication was used.
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imipramine (n=7), clomipramine (n=4), and
nortriptyline (n=1). Twenty-five combinations with
risk of developing drug interaction were identified
in 16 patients (25.3%).
There were 350 admissions to the psychiatric unit
and a total of 311 patients, from January 1993 to De-
cember 1995. Twenty-three patients were admitted
twice, five patients were admitted three times, and two
patients were hospitalized four times in this period.
Out of the total number of patients, 63 patients re-
ceived antidepressants (20.2%). The public hospital
has only a psychiatric unit for female patients. The
antidepressants used were: imipramine (n=37), am-
itriptyline (n=15), clomipramine (n=9), tranylcy-
promine (n=7), moclobemide (n=4), nortriptyline (n=3),
fluoxetine (n=3) and maprotiline (n=2). Fourteen drug
interactions were observed in 13 patients.
There were 87 patients registered in the affective
disorders outpatient clinic in December 1996. Forty-
three of these patients used antidepressants (49.4%).
The antidepressants prescribed, in order of frequency,
were clomipramine (n=12), imipramine (n=7),
sertraline (n=7), fluoxetine (n=6), nortriptyline (n=5),
maprotiline (n=3), moclobemide (n=2), tranylcy-
promine (n=2), paroxetine (n=1), amineptine (n=1),
and mianserin (n=1). Seven drug interactions were
observed in seven patients.
A total of 169 patients received antidepressants and
drug interactions were observed in 36 subjects (Ta-
ble). There were 20 different forms of drug interac-
tion. As to severity, four were minor, 15 moderate and
one major.
DISCUSSION
In the study it was observed that approximately
20% of the patients admitted to a general hospital
with depressive symptoms would benefit from tak-
ing antidepressants. At the public hospital, the pro-
portion of patients using antidepressants in the gen-
eral (non psychiatric) units is quite small (0.9%).
Identifying patients with depressive symptoms and
giving them appropriate treatment not only improves
their quality of life, but also results in better progno-
sis and shorter hospital stay. However, prescription of
antidepressants to patients who are already taking
several medications and suffer from other conditions
(hepatic, renal, cardiac conditions, etc.) requires spe-
cial care regarding possible drug interactions. The
use of a software program makes practice easier at
bedside and in private offices.
A limitation of this study is its small sample size,
particularly in the affective disorders outpatient clinic.
Also it was noted that few of the new antidepressant
drugs are used but this probably reflects the medica-
tions available in public health facilities in Brazil.
Todi et al 14give the following recommendations to
minimize the risk of drug interaction:
1. Check medications every day.
2. Learn about the therapeutic and toxic effects of
each drug.
3. Bear in mind the pharmacokinetic profile of each
drug.
4. Remember that systemic conditions (renal and
hepatic diseases) might require changes in dosage.
An increase in the distribution volume might
require higher doses; and reduced clearance might
require decreased maintenance doses.
5. Check for possible drug interactions.
6. Minimize the number of drugs prescribed.
7. Whenever possible, replace medication with
similarly effective but cheaper drugs. Prescribe
generic drugs if efficacy is similar.
8. Plan monitoring of therapeutic and toxic effects.
Check serum levels properly.
In conclusion, 25% of the patients in the general
hospital units, 20% in the psychiatric unit, and 16%
in affective disorders outpatient clinic of the public
hospital who used antidepressants were exposed to
the risk of drug interactions during the study pe-
riod. In the general units, the number of drug inter-
actions per patient was higher than in the psychiat-
ric unit; and prescription for depression was lower
than expected.
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Table - Drug interactions observed through a software at hospital studied (general and psychiatric units, and affective disorder
outpatient clinic).
General units Psychiatric unit Affective disorder Total
outpatient clinic
Total number of patients 6,844 311 87 7.242
Patients using antidepressants 63 (0.9%) 63 (20.2%) 43 (49.4%) 169 (2.3%)
Patients with drug interactions  *ns 16 (25.3%) 13 (20.6%) 7 (16.2%) 36 (21.3%)
Total number of interactions 25 14 7 46
*ns chi=1.29 p=0.52
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